Finally, to analyze the clinical relevance of TEAD4 in prostate carcinogenesis, the OncomineTM Platform (Thermo Fisher, Ann Arbor, MI) was used for analysis and visualization. This evidence concerns the gene TEAD4 and male reproductive organ cancer.